Drug Development

GLP-1 Receptor Agonists: The Most Exciting Longevity Drug Class of the Decade Semaglutide, tirzepatide, and their next-generation successors have dominated headlines as weight-loss medications. But in 2026, the scientific narrative has shifted dramatically. Researchers and longevity physicians are now recognising GLP-1 receptor agonists (GLP-1 RAs) as a powerful multi-system intervention that may extend healthspan — […]

The GLP-1 Revolution Beyond Weight Loss: A New Chapter in Longevity Medicine In 2026, glucagon-like peptide-1 (GLP-1) receptor agonists have transcended their origins as diabetes and obesity medications to become one of the most closely studied drug classes in longevity science. Semaglutide, tirzepatide, and next-generation dual and triple agonists are now at the centre of